FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316360711> ?p ?o ?g. }

• W2316360711 endingPage "e0150259" @default.
• W2316360711 startingPage "e0150259" @default.
• W2316360711 abstract "Background The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) alongside long-lasting insecticide-treated nets (LLIN) and case management for reducing the risks associated with malaria in pregnancy in areas of moderate-to-high transmission in sub-Saharan Africa. Due to increasing Plasmodium falciparum resistance to SP, the search for alternative drugs or strategies to control malaria in pregnancy is a priority. We assessed the acceptability among pregnant women and health providers of intermittent screening and treatment (ISTp) and IPTp with dihydroartemisinin-piperaquine (DP) as alternative strategies in the context of an un-blinded clinical trial. Methods Qualitative data were collected through ten focus group discussions with women participating in a randomized controlled trial to evaluate ISTp or IPTp with DP (multi-day regimen) versus IPTp with SP (single dose) in western Kenya. Individual in-depth interviews were conducted with 26 health providers working in the trial facilities and trial staff. Results Women appreciated the advantages of being tested with a rapid diagnostic test (RDT) at every ANC visit (although a few women disliked finger pricks) and accepted that they would not receive any antimalarial when tested RDT-negative. There were differences in women’s experiences of the efficacy of antimalarials between the trial arms, with more women in the IPTp-SP arm reporting they had experienced malaria episodes. Side effects were experienced among women taking DP and SP. Although women and trial staff reported adherence to the full DP regimen within the trial, health providers were not confident that women would adhere to multi-day regimens in non-trial settings. Health providers recognized the advantages of ISTp in reducing unnecessary exposure to drugs, but lacked confidence in the reliability of RDTs compared to microscopy. Conclusions Our findings indicate that, within a trial context, ISTp-DP and IPTp-DP were generally acceptable among both users and providers and were regarded as potentially valuable alternatives to IPTp-SP. Several challenges were identified the most important of which was concerns with achieving adherence to DP in non-trial settings, requiring operational feasibility studies in routine health systems. Policy adoption of ISTp with RDTs would require a major shift in thinking among health providers due to lack of confidence in RDTs." @default.
• W2316360711 created "2016-06-24" @default.
• W2316360711 creator A5006637618 @default.
• W2316360711 creator A5014276524 @default.
• W2316360711 creator A5030170744 @default.
• W2316360711 creator A5056227550 @default.
• W2316360711 creator A5057453414 @default.
• W2316360711 creator A5061004254 @default.
• W2316360711 creator A5064670919 @default.
• W2316360711 creator A5073562016 @default.
• W2316360711 date "2016-03-17" @default.
• W2316360711 modified "2023-10-02" @default.
• W2316360711 title "User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya" @default.
• W2316360711 cites W1589156205 @default.
• W2316360711 cites W1977731028 @default.
• W2316360711 cites W1992589768 @default.
• W2316360711 cites W1998021936 @default.
• W2316360711 cites W2005653369 @default.
• W2316360711 cites W2006928697 @default.
• W2316360711 cites W2014130091 @default.
• W2316360711 cites W2017672792 @default.
• W2316360711 cites W2019358007 @default.
• W2316360711 cites W2046363656 @default.
• W2316360711 cites W2065151287 @default.
• W2316360711 cites W2072106088 @default.
• W2316360711 cites W2082480743 @default.
• W2316360711 cites W2097681192 @default.
• W2316360711 cites W2102280420 @default.
• W2316360711 cites W2107150651 @default.
• W2316360711 cites W2112365949 @default.
• W2316360711 cites W2114060450 @default.
• W2316360711 cites W2128052069 @default.
• W2316360711 cites W2129955913 @default.
• W2316360711 cites W2147671759 @default.
• W2316360711 cites W2149445898 @default.
• W2316360711 cites W2153584506 @default.
• W2316360711 cites W2160365634 @default.
• W2316360711 cites W2559485779 @default.
• W2316360711 doi "https://doi.org/10.1371/journal.pone.0150259" @default.
• W2316360711 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4795545" @default.
• W2316360711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26986471" @default.
• W2316360711 hasPublicationYear "2016" @default.
• W2316360711 type Work @default.
• W2316360711 sameAs 2316360711 @default.
• W2316360711 citedByCount "24" @default.
• W2316360711 countsByYear W23163607112016 @default.
• W2316360711 countsByYear W23163607112018 @default.
• W2316360711 countsByYear W23163607112019 @default.
• W2316360711 countsByYear W23163607112020 @default.
• W2316360711 countsByYear W23163607112021 @default.
• W2316360711 countsByYear W23163607112022 @default.
• W2316360711 countsByYear W23163607112023 @default.
• W2316360711 crossrefType "journal-article" @default.
• W2316360711 hasAuthorship W2316360711A5006637618 @default.
• W2316360711 hasAuthorship W2316360711A5014276524 @default.
• W2316360711 hasAuthorship W2316360711A5030170744 @default.
• W2316360711 hasAuthorship W2316360711A5056227550 @default.
• W2316360711 hasAuthorship W2316360711A5057453414 @default.
• W2316360711 hasAuthorship W2316360711A5061004254 @default.
• W2316360711 hasAuthorship W2316360711A5064670919 @default.
• W2316360711 hasAuthorship W2316360711A5073562016 @default.
• W2316360711 hasBestOaLocation W23163607111 @default.
• W2316360711 hasConcept C126322002 @default.
• W2316360711 hasConcept C151730666 @default.
• W2316360711 hasConcept C168563851 @default.
• W2316360711 hasConcept C203014093 @default.
• W2316360711 hasConcept C2776120307 @default.
• W2316360711 hasConcept C2777035104 @default.
• W2316360711 hasConcept C2777616469 @default.
• W2316360711 hasConcept C2778048844 @default.
• W2316360711 hasConcept C2778301690 @default.
• W2316360711 hasConcept C2778371730 @default.
• W2316360711 hasConcept C2779234561 @default.
• W2316360711 hasConcept C2779343474 @default.
• W2316360711 hasConcept C2781413609 @default.
• W2316360711 hasConcept C512399662 @default.
• W2316360711 hasConcept C54355233 @default.
• W2316360711 hasConcept C71924100 @default.
• W2316360711 hasConcept C86803240 @default.
• W2316360711 hasConcept C99454951 @default.
• W2316360711 hasConceptScore W2316360711C126322002 @default.
• W2316360711 hasConceptScore W2316360711C151730666 @default.
• W2316360711 hasConceptScore W2316360711C168563851 @default.
• W2316360711 hasConceptScore W2316360711C203014093 @default.
• W2316360711 hasConceptScore W2316360711C2776120307 @default.
• W2316360711 hasConceptScore W2316360711C2777035104 @default.
• W2316360711 hasConceptScore W2316360711C2777616469 @default.
• W2316360711 hasConceptScore W2316360711C2778048844 @default.
• W2316360711 hasConceptScore W2316360711C2778301690 @default.
• W2316360711 hasConceptScore W2316360711C2778371730 @default.
• W2316360711 hasConceptScore W2316360711C2779234561 @default.
• W2316360711 hasConceptScore W2316360711C2779343474 @default.
• W2316360711 hasConceptScore W2316360711C2781413609 @default.
• W2316360711 hasConceptScore W2316360711C512399662 @default.
• W2316360711 hasConceptScore W2316360711C54355233 @default.
• W2316360711 hasConceptScore W2316360711C71924100 @default.
• W2316360711 hasConceptScore W2316360711C86803240 @default.
• W2316360711 hasConceptScore W2316360711C99454951 @default.

• next